3 Common Misconceptions in Spatial Transcriptome Data Analysis

If you’re familiar with single-cell data, you already know the massive leap spatial transcriptomes offers: Spatial analysis can advantageously tell us where they are and how they interact, specifically by preserving spatial context, tissue architecture or niche environments. Yet bridging that gap isn't always straightforward. In this post, we’ll break down 3 common misconceptions when analyzing spatial transcriptome data we have seen - and some of our few tips to optimize your pipeline.

Misconception #1: All Spatial Transcriptome Provides Single-Cell Resolution

First and foremost, not all spatial transcriptome data is provided at single-cell resolution. Techniques like 10x Genomics Xenium and NanoString CosMx are known for achieving single-cell resolution but earlier technologies such as 10x Visium doesn’t have that feature. The difference comes from their underlying approaches: methods like Visium are sequencing-based, rather than imaging-based (such as Xenium, which uses fluorescence microscopy to capture images). In Visium, cells fall in predefined spots, then these cells are labelled with the spot’s positional information, then be sequenced. However, these spots are relatively large (around 10–50 μm), so each one may contain multiple cells.

Hence, before doing downstream analysis, it is critical to verify the native resolution of your platform. If you are working with sequencing-based methods like Visium, you must avoid the common pitfall of treating each data point as a single cell; instead, utilize deconvolution algorithms (such as RCTD, Stereoscope, or Seurat’s Label Transfer) to "unmix" the multicellular signals within each spot.[1] Conversely, if you are using imaging-based platforms like Xenium or CosMx, your priority should shift toward robust cell segmentation.

Misconception #2: Standard Single-Cell RNA-seq (scRNA-seq) Tools are Sufficient

Another common trap is assuming that pipelines designed for dissociated single cells are enough for spatial transcriptome analysis. These tools are excellent for clustering but they often treat each data point as an independent "bag of genes" without spatial information. The defining feature of a spatial transcriptome is its spatial coordinates and spatial autocorrelation - biological reality that a cell’s identity and function are heavily influenced by its immediate similar cellular neighbors. When you strip away the coordinates, you lose the ability to see how tissue architecture drives biology.

Hence, sometimes using tools that incorporate spatial coordinates directly into the mathematical models helps a lot. An example is the framework for the robust mapping of spatiotemporal trajectories and cell-cell interactions.[2] Unlike standard scRNA-seq tools that might suggest two cells are identical because they share a gene signature, this spatial approach can reveal how those same cells behave differently depending on their "niche" (e.g., near a blood vessel versus the center of a tumor).

In a standard scRNA-seq dataset, you can predict that Cell A might talk to Cell B because one has a Ligand (L) and the other has a Receptor (R). However, if those cells were on opposite sides of a tumor in the actual tissue, that conversation never happened. The spatial tool in our example, however, verifies these interactions by checking for physical colocalization: If the expression of a receptor in a Macrophage significantly increases only when it is within a few micrometers of a T-cell, the spatial model identifies this as a "niche-induced" state. Moreover, cells often exist on a spectrum of development or exhaustion, and spatial analysis allows us to map these trajectories across a physical gradient. Hence, two cells of the exact same "type" will express different genes depending on where they sit on that gradient. Spatial trajectories show us how a cell "travels" through different states as it moves from, for example, the healthy outer layer of an organ into an inflamed or hypoxic core.

So by factoring in spatial proximity, this method infers cell-cell interactions and developmental trajectories that are physically grounded in the tissue’s 3D architecture. To get the most out of your data, we recommend utilizing dedicated spatial analysis tools rather than relying solely on scRNA-seq pipelines. Treating spatial transcriptome data as 'disassociated' single-cell data is a missed opportunity, as it discards the vital spatial coordinates that provide biological context.

Misconception #3: All spatial technologies can follow the same analysis workflow

Another critical oversight is the assumption that all spatial transcriptomes can be funneled through a single, standardized pipeline. In reality, the "best" workflow is dictated by how the data was captured, either via Next-Generation Sequencing (NGS) or in situ imaging.

NGS-based methods, such as 10x Visium, provide an unbiased, whole-transcriptome view (20,000+ genes) but at lower spatial resolution. More specifically, for example, Pathway Enrichment (like GSEA) works by looking for clusters of related genes that are turned "on" or "off" together; with NGS, you have all of them, giving you the statistical "weight" needed to confirm the pathway's activity. Therefore, these datasets are "discovery engines” and are perfectly suited for pathway enrichment, gene module detection and identifying broad differential expression across tissue regions.

In contrast, in situ technologies like Xenium or CosMx SMI use targeted panels of only hundreds or a few thousand genes. While they "see" fewer genes, they provide sub-cellular resolution and cleaner signals with less background noise. Because of this high precision, these platforms are better suited for mapping exact cell-type boundaries and investigating the "local conversations" of cell-cell interactions. Applying a discovery-style workflow to a targeted panel, or a high-resolution workflow to a low-resolution spot, may ignore the unique strengths of each technology and often leads to misleading biological conclusions.

Streamlining spatial transcriptome data analysis with C-DIAM

By supporting multiple spatial technologies (Visium, Visium HD, Xenium, CosMx, Stereo-seq), our CDIAM Multi-Omics Studio platform is designed to make it easier to evaluate and work across diverse spatial transcriptome datasets without being locked into a single workflow. Researchers can seamlessly import and share data in standard formats such as count matrices coupled with spatial images and Scanpy objects, enabling smoother collaboration between pathologists, bioinformaticians, and bench scientists. With an interactive, user-friendly GUI, teams can quickly run and compare different analytical approaches without extensive coding.

Discover and try out C-DIAM for your next projects:

References

[1] Yingkun Zhang, Xinrui Lin, Zhixian Yao, Di Sun, Xin Lin, Xiaoyu Wang, Chaoyong Yang, Jia Song,

Deconvolution algorithms for inference of the cell-type composition of the spatial transcriptome,

Computational and Structural Biotechnology Journal, Volume 21, 2023, Pages 176-184, ISSN 2001-0370, https://doi.org/10.1016/j.csbj.2022.12.001.

[2] Pham, D., Tan, X., Balderson, B. et al. Robust mapping of spatiotemporal trajectories and cell–cell interactions in healthy and diseased tissues. Nat Commun 14, 7739 (2023). https://doi.org/10.1038/s41467-023-43120-6.